Clinical Trials Browser

Phase 2 × Chordoma × Immunoglobulin G × Clear all

NCT03623854 2024-04-16

Nivolumab and Relatlimab in Treating Participants With Advanced Chordoma

Phase 2 Completed

Chordoma